We will present our work about the generation of functional human liver organoids with BIOMIMESYS® in CNRS thematic school

This week we will present at the thematic school “From 3D culture to the organoid: multidisciplinary research” organised by the Institute of Biological Sciences of CNRS (France) in Strasbourg. Study director Méryl Roudaut will talk about the generation of functional human liver organoids using hiPSC and our innovative 3D cell Read more…

A representative hematoxylin and eosin staining of UV-induced skin tumor or skin obtained from SKH-1 mice colonized by S. epidermidis 1457 or MO34, respectively, treated with UV-B for 12 weeks.

We update our services in dermocosmetology for Skin Pigmentation and Oxidative Stress

Summer is alway a good time to improve our services. Then we are very happy to introduce our updated Skin Pigmentation and Oxidative Stress services. Pigmentation is particularly regulated  at  the  cellular  level  by  melanocytes synthesizing  melanin  within  melanosomes,  which  can be  produced  in  varying  sizes,  numbers,  and  densities. In order to evaluate Read more…

Robin and Orégane join us to develop a microfluidic system for mechanical sollicitation of cancer spheroids

As part of their engineering studies at ISEN Lille for a master’s degree specialized in Bionanotechnologies, Robin and Orégane arrived in HCS Pharma in May 2021 for a 4-month internship. Their work in HCS Pharma follows a student project during which they designed and computationally simulated a microfluidic device capable Read more…

Development of HCS Pharma in Taïwan with an incubation process in the famous NHRI

We are really pleased to announce that we have officially created a representative office in Taïwan (company 仿生培養技術中心 ID number 90729614) which is directed by our partner, Joseph Chou 周肇隆 ジョーゼフ・チョウ, member of our advisory board. Thanks to Joseph and Professor Szecheng J. Lo, member of our scientific advisory board, all Read more…

Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models

We are very happy to invite you to our next webinar about 3D cellular cancer models and our BIOMIMESYS® Oncology matrix which allows cancer cells to be cultured in a tumor-like environment, with the possibility to tune the composition and stiffness of the matrix. We will also share our best Read more…